title: Quantitation of T cell depletion by limiting dilution analysis.
abstract: BACKGROUND
  We evaluated a culture method for enumeration of residual T cells remaining in marrow after treatment with antibody and complement or with immunotoxin.
  
  
  METHODS
  Marrow cells were cultured at limiting dilutions with phytohemagglutinin in the presence of Epstein Barr virus transformed human lymphoblastoid cells, and supernates were tested three days later for IL-2 by a cell proliferation assay. This method provides a simple, reliable, objective and rapid enumeration of T cells in marrow before and after treatment.
  
  
  RESULTS
  Approximately 6% of untreated marrow mononuclear cells can produce IL-2 in such clonal cultures. Treatment with antibodies and complement under conditions identical to those used for our previous clinical trials produced a 3.7 log depletion of IL-2 precursors, whereas treatment with a ricin A chain anti-CD3 immunotoxin produced a 3.0 log depletion.
  
  
  CONCLUSIONS
  Clinical correlations are in progress for assessing whether T cell depletion evaluated with the present method equals previous techniques. The extreme depletion of T cells accomplished by these methods may partly account for the high graft failure rate seen in our clinical trials.
authors.affiliation: Divisione di Ematologia, USL n. 3, Pesaro, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Moretti
authors.forename: S
authors.initials: S
authors.lastname: Corpuz
authors.forename: L
authors.initials: L
authors.lastname: Giuliodori
authors.forename: S
authors.initials: S
authors.lastname: Stramigioli
authors.forename: P J
authors.initials: PJ
authors.lastname: Martin
mesh_terms: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D001854:Bone Marrow Cells; D017252:CD3 Complex; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D003165:Complement System Proteins; D004854:Herpesvirus 4, Human; D006801:Humans; D000922:Immunotoxins; D007376:Interleukin-2 / Q000032:analysis*; D007958:Leukocyte Count / Q000379:methods*; D008213:Lymphocyte Activation / Q000187:drug effects; D008212:Lymphocyte Depletion / Q000379:methods; D010835:Phytohemagglutinins; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012276:Ricin; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D000922:Immunotoxins; D007376:Interleukin-2; D010835:Phytohemagglutinins; D011948:Receptors, Antigen, T-Cell; D003165:Complement System Proteins; D012276:Ricin